NoIR 11% Dark Gray SpectraShield Medium 422-36
by NoIR
Last verified June 19, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
These are specialized wraparound sunglasses with dark gray lenses that block 89% of visible light while transmitting 11%, providing full UV and blue light filtering for people with serious light sensitivity. They're designed for individuals living with conditions like glaucoma, diabetic retinopathy, or post-cataract surgery, where bright light or glare causes significant discomfort or vision disruption. The frame includes a solid top ledge and filtered side windows to block light from all angles — not just straight ahead — and they fit over most prescription glasses. At this transmission level, these are appropriate for bright outdoor environments; they may be too dark for indoor use or low-light conditions, so people with fluctuating light sensitivity often need more than one pair at different transmission levels.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
What Setup Looks Like
- Out of the box
- Put them on — they work as-is, including over prescription eyewear.
- If used post-surgery or for a diagnosed condition, confirm the tint level is appropriate for your lighting environment before relying on them outdoors.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR — view on vendor site; last verified June 19, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.